Zobrazeno 1 - 10
of 254
pro vyhledávání: '"Akira Shirahata"'
Autor:
Shun Ichikawa, Shunsuke Araki, Daisuke Shimizu, Koichi Kusuhara, Akira Shirahata, Masayuki Ochiai, Satoshi Ibara
Publikováno v:
Pediatrics and Neonatology, Vol 65, Iss 3, Pp 237-241 (2024)
Background: Neonatal disseminated intravascular coagulation (DIC) is a rare disease with a poor outcome. However, data on the incidence, treatment, and outcome of neonatal DIC are scarce. Thus, this study investigated the status of neonatal DIC in Ja
Externí odkaz:
https://doaj.org/article/7d5f477c699b4d11ac4c34306429b53d
Autor:
Shunsuke Araki, Akira Shirahata
Publikováno v:
Nutrients, Vol 12, Iss 3, p 780 (2020)
Vitamin K is essential for the synthesis of few coagulation factors. Infants can easily develop vitamin K deficiency owing to poor placental transfer, low vitamin K content in breast milk, and poor intestinal absorption due to immature gut flora and
Externí odkaz:
https://doaj.org/article/54d252fd1a0642e5a629751b934cc9ab
Autor:
Naoya Morisada, Masayoshi Nomura, Hisae Nishii, Yumi Furuno, Mayuko Sakanashi, Ken Sabanai, Yumiko Toyohira, Susumu Ueno, Seiji Watanabe, Masahito Tamura, Tetsuro Matsumoto, Akihide Tanimoto, Yasuyuki Sasaguri, Hiroaki Shimokawa, Koichi Kusuhara, Nobuyuki Yanagihara, Akira Shirahata, Masato Tsutsui
Publikováno v:
Journal of Pharmacological Sciences, Vol 114, Iss 4, Pp 379-389 (2010)
Abstract.: The role of nitric oxide (NO) derived from all three NO synthases (NOSs) in renal lesion formation remains to be fully elucidated. We addressed this point in mice lacking all NOSs. Renal injury was induced by unilateral ureteral obstructio
Externí odkaz:
https://doaj.org/article/ce00b35f732f45f1b7369366aef7d29a
Autor:
Daijiro Takahashi, Tomohiko Nakamura, Reiko Shigematsu, Miyu Matsui, Shunsuke Araki, Kazuyasu Kubo, Hiroshi Sato, Akira Shirahata
Publikováno v:
International Journal of Pediatrics, Vol 2009 (2009)
We conducted a retrospective case series study to evaluate the safety of fosfluconazole prophylaxis for preventing invasive fungal infection in VLBW infants with a central vascular access. Fosfluconazole was administered intravenously at a dose of 6
Externí odkaz:
https://doaj.org/article/04c91866a5e7480687fd58bf694b68a5
Autor:
Michio, Sakai, Kagehiro, Amano, Motoaki, Chin, Hideyuki, Takedani, Hiroyuki, Ishida, Kazuo, Sakashita, Masashi, Taki, Masahiro, Migita, Hiroyoshi, Watanabe, Masataka, Ishimura, Keiji, Nogami, Sho, Harano, Akira, Shirahata
Publikováno v:
Haemophilia. 29:456-465
Haemophilia B patients with factor IX inhibitors have particularly unmet needs for conventional therapy.Phase II/III clinical trial, multicentre, open-label, prospective, self-controlled study was conducted to assess MC710 prophylaxis in haemophilia
Autor:
Keiji, Nogami, Masashi, Taki, Tadashi, Matsushita, Tetsuhito, Kojima, Toshiaki, Oka, Shouichi, Ohga, Kiyoshi, Kawakami, Michio, Sakai, Takashi, Suzuki, Satoshi, Higasa, Yasuo, Horikoshi, Keiko, Shinozawa, Shogo, Tamura, Koji, Yada, Masue, Imaizumi, Yoshitoshi, Ohtsuka, Fuminori, Iwasaki, Masao, Kobayashi, Junki, Takamatsu, Hideyuki, Takedani, Hisaya, Nakadate, Yoko, Matsuo, Takeshi, Matsumoto, Teruhisa, Fujii, Katsuyuki, Fukutake, Akira, Shirahata, Akira, Yoshioka, Midori, Shima
Publikováno v:
Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES. 28(5)
Inhibitor-development is a serious complication in patients with haemophilia (PwH). Previous studies reported that therapeutic and genetic factors could be associated with these alloantibodies. Relevant clinical features such as genetic-background an
More than 40 years history with the aim of extermination of vitamin K deficiency bleeding in infancy
Autor:
Akira Shirahata
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 31:340-344
Autor:
Katsuyuki Fukutake, Hiroshi Takagi, Werner Engl, Junki Takamatsu, Tadashi Matsushita, Morio Arai, Midori Shima, Akira Shirahata, Haruhiko Uchikawa, Keiji Nogami, Akira Yoshioka, Masashi Taki
Publikováno v:
International Journal of Hematology. 109:336-345
Rurioctocog alfa (recombinant Factor VIII: AdvateⓇ) is available for the control of bleeding in patients with hemophilia A in Japan. To evaluate the immunogenicity, safety, and efficacy of prophylactic and on-demand use of rurioctocog alfa, postmar
Autor:
Keiko Shinozawa, Katsuyuki Fukutake, Akira Shirahata, Midori Shima, Keiji Nogami, Koji Yada, Akira Yoshioka, Tetsuhito Kojima, Masashi Taki
Publikováno v:
Thrombosis and haemostasis. 121(5)
Some genetic and treatment-related factors are risk factors for inhibitor development in patients with hemophilia A (PwHA). However, the genotype distribution of the factor VIII gene (F8) and genetic impact on inhibitor development in Japanese PwHA r
Autor:
Masashi Taki, Katsuyuki Fukutake, Tadashi Matsushita, Keiji Nogami, Midori Shima, Akira Yoshioka, Junki Takamatsu, Morio Arai, Hiroshi Takagi, Haruhiko Uchikawa, Werner Engl, Akira Shirahata
Publikováno v:
International Journal of Hematology. 109:70-78